This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
C$0.01859
Share price
-33.50%
Change (1 day)
-98.91%
Change (1 year)
Categories
Earnings for Athersys (ATHX)
Earnings in 2023 (TTM): -C$56.23 Million
According to Athersys's latest financial reports the company's current earnings are C$0.08 Million. In 2022 the company made an earning of -C$0.11 Billion, an increase over its 2021 earnings that were of -C$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Athersys from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -C$56.23 Million | -46.98% |
| 2022 | -C$0.11 Billion | -11.54% |
| 2021 | -C$0.12 Billion | 11.14% |
| 2020 | -C$0.11 Billion | 72.2% |
| 2019 | -C$62.64 Million | 77.29% |
| 2018 | -C$35.33 Million | -22.91% |
| 2017 | -C$45.83 Million | 111.89% |
| 2016 | -C$21.63 Million | -8.52% |
| 2015 | -C$23.65 Million | -40.81% |
| 2014 | -C$39.95 Million | 18.62% |
| 2013 | -C$33.68 Million | |
| 2011 | -C$18.98 Million | 19.71% |
| 2010 | -C$15.85 Million | -26.28% |
| 2009 | -C$21.5 Million | -18.21% |
| 2008 | -C$26.29 Million | -8.28% |
| 2007 | -C$28.66 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | C$9.15 B | -16,023.57% | 🇺🇸 USA |
 Pfizer PFE | C$14.23 B | -24,861.75% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | C$8.40 B | -14,725.74% | 🇺🇸 USA |
 Moderna
MRNA | -C$4.67 Billion | 8,010.24% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$37.73 B | -65,729.04% | 🇺🇸 USA |
 United States Lime & Minerals USLM | C$0.20 B | -461.74% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | -C$0.87 Billion | 1,401.18% | 🇺🇸 USA |
 Merck MRK | C$29.53 B | -51,462.48% | 🇺🇸 USA |
 Sanofi SNY | C$12.07 B | -21,097.75% | 🇫🇷 France |